Conditions | Yield |
---|---|
With potassium hydrosulfide und Erwaermen des Reaktionsprodukts mit einem Gemisch von Jod, konz.HI und rotem Phosphor; |
[1,3]thiazolo[5,4-d]pyrimidin-7-amine
formamide
6H-purine-6-thione
Conditions | Yield |
---|---|
at 190℃; | |
at 190℃; |
6-amino-5-formylamino-3H-pyrimidin-4-one
6H-purine-6-thione
Conditions | Yield |
---|---|
With pyridine; tetraphosphorus decasulfide | |
With tetraphosphorus decasulfide; tetralin |
N-(4-amino-6-thioxo-1,6-dihydro-pyrimidin-5-yl)-formamide
6H-purine-6-thione
Conditions | Yield |
---|---|
With formamide at 200℃; |
5-Aminoimidazole-4-thioamide
formamide
6H-purine-6-thione
Conditions | Yield |
---|---|
at 200℃; |
Conditions | Yield |
---|---|
With ethanol |
Conditions | Yield |
---|---|
With tetraphosphorus decasulfide; tetralin | |
With pyridine; tetraphosphorus decasulfide | |
Multi-step reaction with 2 steps 1: N,N-dimethyl-aniline; POCl3 2: ethanol View Scheme |
S6-(N-methyl-N-methoxycarbonyl)aminomethyl-6-mercaptopurine
6H-purine-6-thione
Conditions | Yield |
---|---|
With phosphate buffer; water at 32℃; Rate constant; Mechanism; pH 7.1; |
S6-(N-methyl-N-ethoxycarbonyl)aminomethyl-6-mercaptopurine
6H-purine-6-thione
Conditions | Yield |
---|---|
With phosphate buffer; water at 32℃; Rate constant; pH 7.1; |
S6-(N-ethyl-N-methoxycarbonyl)aminomethyl-6-mercaptopurine
6H-purine-6-thione
Conditions | Yield |
---|---|
With phosphate buffer; water at 32℃; Rate constant; pH 7.1; |
S6-(N-ethyl-N-ethoxycarbonyl)aminomethyl-6-mercaptopurine
6H-purine-6-thione
Conditions | Yield |
---|---|
With phosphate buffer; water at 32℃; Rate constant; pH 7.1; |
S6-(N-butyl-N-methoxycarbonyl)aminomethyl-6-mercaptopurine
6H-purine-6-thione
Conditions | Yield |
---|---|
With phosphate buffer; water at 32℃; Rate constant; pH 7.1; |
S6-(N-methyl-N-butoxycarbonyl)aminomethyl-6-mercaptopurine
6H-purine-6-thione
Conditions | Yield |
---|---|
With phosphate buffer; water at 32℃; Rate constant; pH 7.1; |
acetic anhydride
7-(dimethylamino)methyl-6-mercaptopurine
A
6H-purine-6-thione
B
7-acetyloxymethyl-6-mercaptopurine
C
9-acetyloxymethyl-6-mercaptopurine
D
S6,3-bisacetyloxymethyl-6-mercaptopurine
Conditions | Yield |
---|---|
With sodium acetate In dimethylsulfoxide-d6 for 20h; Ambient temperature; Yield given. Yields of byproduct given. Title compound not separated from byproducts; |
6-thiocyanato-7(9)H-purine
tetrachloromethane
water
6H-purine-6-thione
Conditions | Yield |
---|---|
at 25℃; Kinetics; |
6H-purine-6-thione
Conditions | Yield |
---|---|
at 240℃; |
8-chloroxanthine
6H-purine-6-thione
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: N,N-dimethyl-aniline; POCl3 2: aqueous KHS / und Erwaermen des Reaktionsprodukts mit einem Gemisch von Jod, konz.HI und rotem Phosphor View Scheme |
N-(4-amino-6-benzylsulfanyl-pyrimidin-5-yl)-formamide
6H-purine-6-thione
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: sodium; liquid NH3 2: formamide / 200 °C View Scheme |
Conditions | Yield |
---|---|
With triethylamine In ethanol for 24h; Reflux; Inert atmosphere; Schlenk technique; Darkness; | 89% |
Conditions | Yield |
---|---|
With potassium hydroxide In water; N,N-dimethyl-formamide for 2h; | 87% |
6H-purine-6-thione
Conditions | Yield |
---|---|
Stage #1: 6H-purine-6-thione; C24H24Cl2N4Ru With triethylamine In ethanol for 24h; Reflux; Inert atmosphere; Schlenk technique; Darkness; Stage #2: ammonium hexafluorophosphate In ethanol; water Inert atmosphere; Schlenk technique; Darkness; | 83% |
6H-purine-6-thione
N-(4-Nitrobenzoyl)-1-pyrrolidinecarbimidoyl Chloride
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide at 80℃; for 1.5h; | 72% |
D-glucose pentaacetate
6H-purine-6-thione
Conditions | Yield |
---|---|
Stage #1: 6H-purine-6-thione With ammonium sulfate; chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane; saccharin In acetonitrile for 5h; Vorbrueggen Nucleoside Synthesis; Reflux; Inert atmosphere; Stage #2: D-glucose pentaacetate With trimethylsilyl trifluoromethanesulfonate In acetonitrile for 3h; Vorbrueggen Nucleoside Synthesis; Inert atmosphere; Reflux; | 68% |
6H-purine-6-thione
D-galactose pentaacetate
Conditions | Yield |
---|---|
Stage #1: 6H-purine-6-thione With ammonium sulfate; chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane; saccharin In acetonitrile for 5h; Vorbrueggen Nucleoside Synthesis; Reflux; Inert atmosphere; Stage #2: D-galactose pentaacetate With trimethylsilyl trifluoromethanesulfonate In acetonitrile for 3h; Vorbrueggen Nucleoside Synthesis; Inert atmosphere; Reflux; | 63% |
6H-purine-6-thione
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide 1.) 80 deg C, 5 h, 2.) RT, 2 d; | 62% |
6H-purine-6-thione
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide 1.) 80 deg C, 5 h, 2.) RT, 2 d; | 60% |
6H-purine-6-thione
Conditions | Yield |
---|---|
With NaOH In methanol; water org. ligand suspended in aq. MeOH; pH adjusted to 8-9 (aq. NaOH); Ru complex added; mixt. refluxed for 3 h at 90°C; cooled to room temp.;NaClO4 added; mixt. concd. by rotary evaporator; recrystd. (H2O/MeOH); elem. anal.; | 60% |
6H-purine-6-thione
1,2,3,4-tetra-O-acetyl-D-xylopyranose
Conditions | Yield |
---|---|
Stage #1: 6H-purine-6-thione With ammonium sulfate; chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane; saccharin In acetonitrile for 5h; Vorbrueggen Nucleoside Synthesis; Reflux; Inert atmosphere; Stage #2: 1,2,3,4-tetra-O-acetyl-D-xylopyranose With trimethylsilyl trifluoromethanesulfonate In acetonitrile for 3h; Vorbrueggen Nucleoside Synthesis; Inert atmosphere; Reflux; | 60% |
1,2,3,4-Tetra-O-acetyl-D-lyxopyranose
6H-purine-6-thione
Conditions | Yield |
---|---|
Stage #1: 6H-purine-6-thione With ammonium sulfate; chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane; saccharin In acetonitrile for 5h; Vorbrueggen Nucleoside Synthesis; Reflux; Inert atmosphere; Stage #2: 1,2,3,4-Tetra-O-acetyl-D-lyxopyranose With trimethylsilyl trifluoromethanesulfonate In acetonitrile for 3h; Vorbrueggen Nucleoside Synthesis; Inert atmosphere; Reflux; | 58% |
D-Mannose pentaacetate
6H-purine-6-thione
Conditions | Yield |
---|---|
Stage #1: 6H-purine-6-thione With ammonium sulfate; chloro-trimethyl-silane; 1,1,1,3,3,3-hexamethyl-disilazane; saccharin In acetonitrile for 5h; Vorbrueggen Nucleoside Synthesis; Reflux; Inert atmosphere; Stage #2: D-Mannose pentaacetate With trimethylsilyl trifluoromethanesulfonate In acetonitrile for 3h; Vorbrueggen Nucleoside Synthesis; Inert atmosphere; Reflux; | 55% |
Conditions | Yield |
---|---|
With potassium hydroxide In ethanol; water for 2h; | 53% |
6H-purine-6-thione
Chloromethyl pivalate
A
S6,9-bispivaloyloxymethyl-6-mercaptopurine
Conditions | Yield |
---|---|
With triethylamine In dichloromethane Ambient temperature; | A 45% B 8% C 0.3% D 1% |
6H-purine-6-thione
bis(6-purinyl) disulfide
Conditions | Yield |
---|---|
With iodine; potassium iodide In phosphate buffer at 40℃; pH=7.5; | 41% |
6H-purine-6-thione
6-Bromo-2-(1-bromoethyl)-3-phenyl-4H-chromen-4-one
2-(1-(9H-Purin-6-ylthio)ethyl)-6-bromo-3-phenyl-4H-chromen-4-one
Conditions | Yield |
---|---|
Stage #1: 6H-purine-6-thione With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.166667h; Stage #2: 6-Bromo-2-(1-bromoethyl)-3-phenyl-4H-chromen-4-one In N,N-dimethyl-formamide for 12h; | 37% |
6H-purine-6-thione
fac-[CoCl3(1,4,7-triazacyclononane)]
Conditions | Yield |
---|---|
With NaOH; Sephadex A-25, ClO4-form In water pH-adjustment of soln. of equimolar amts. Co-complex and purine to 8-9 (NaOH, repeated evapn. to dryness at 60°C (stirring) and dissoln. in water; concn., filtration off of trimer, chromy. (Sephadex C25, ClO4-form, hot water), crystn. (two crops); elem. anal.; | A 20% B 36% |
6H-purine-6-thione
N-[1-Chloro-1-piperidin-1-yl-meth-(Z)-ylidene]-4-nitro-benzamide
Conditions | Yield |
---|---|
With triethylamine In N,N-dimethyl-formamide for 72h; Ambient temperature; | A 32% B 35% |
6H-purine-6-thione
2-(Bromomethyl)-3-phenyl-4H-chromen-4-one
2-((9H-Purin-6-ylthio)methyl)-3-phenyl-4H-chromen-4-one
Conditions | Yield |
---|---|
Stage #1: 6H-purine-6-thione With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.166667h; Stage #2: 2-(Bromomethyl)-3-phenyl-4H-chromen-4-one In N,N-dimethyl-formamide for 12h; | 33% |
6H-purine-6-thione
6-Bromo-2-(bromomethyl)-3-phenyl-4H-chromen-4-one
2-[(9H-Purin-6-ylthio)methyl]-6-bromo-3-phenyl-4H-chromen-4-one
Conditions | Yield |
---|---|
Stage #1: 6H-purine-6-thione With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.166667h; Stage #2: 6-Bromo-2-(bromomethyl)-3-phenyl-4H-chromen-4-one In N,N-dimethyl-formamide for 12h; | 28% |
6H-purine-6-thione
Conditions | Yield |
---|---|
Stage #1: 6H-purine-6-thione; C29H23ClN5Ru In methanol; water Reflux; Inert atmosphere; Schlenk technique; Darkness; Stage #2: ammonium hexafluorophosphate In ethanol; water Inert atmosphere; Schlenk technique; Darkness; | 27% |
Conditions | Yield |
---|---|
With triethylamine In ethanol for 24h; Reflux; Inert atmosphere; Schlenk technique; Darkness; | 27% |
6H-purine-6-thione
Conditions | Yield |
---|---|
With triethylamine In methanol; water Reflux; Darkness; Schlenk technique; Inert atmosphere; | 16% |
Conditions | Yield |
---|---|
With hydrogen bromide In water at 70℃; for 3h; pH=Ca. 1 - 2; | 3.8% |
Conditions | Yield |
---|---|
In dimethyl sulfoxide Ambient temperature; | 2.5% |
Conditions | Yield |
---|---|
With sodium hydroxide; diethyl ether |
2-Chloromethylthiophene
6H-purine-6-thione
6-[2]thienylmethylsulfanyl-7(9)H-purine
Conditions | Yield |
---|---|
With potassium carbonate; N,N-dimethyl-formamide |
Conditions | Yield |
---|---|
With ethanol |
IARC Cancer Review: Group 3 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 ,1987,p. 240.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 26 ,1981,p. 249.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 26 ,1981,p. 249.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . NCI Carcinogenesis Studies (ipr); Equivocal Evidence: rat CANCAR Cancer. 40 (1977),1935. ; (ipr); Clear Evidence: mouse CANCAR Cancer. 40 (1977),1935. . EPA Genetic Toxicology Program.
6-Mercaptopurine, with the CAS NO.50-44-2, is an immunosuppressive drug. It has the Synonyms of LEUKERIN; 1,7-Dihydro-6H-purine-6-thione; 7H-PURINE-6-THIOL; 7-mercapto-1,3,4,6-tetrazaindene; 6-MERCAPTOPURINE; 6-PURINETHIOL; 6-THIOPURINE; 6-thioxopurine. It is used to treat leukemia, pediatric non-Hodgkin's lymphoma,[citation needed] polycythemia vera, psoriatic arthritis, and inflammatory bowel disease. 6-Mercaptopurine can be obtained by the reaction of seq xanthine with phosphorus pentasulfide.
Physical properties about 6-Mercaptopurine are: (1)ACD/LogP: -0.632; (2)ACD/LogD (pH 5.5): -0.64; (3)ACD/LogD (pH 7.4): -0.82; (4)ACD/BCF (pH 5.5): 1.00; (5)ACD/BCF (pH 7.4): 1.00; (6)ACD/KOC (pH 5.5): 10.71; (7)ACD/KOC (pH 7.4): 6.95; (8)#H bond acceptors: 4; (9)#H bond donors: 2; (10)Index of Refraction:1.941; (11)Molar Refractivity: 40.028 cm3; (12)Molar Volume: 83.36 cm3; (13)Polarizability:15.868 10-24cm3; (14)Surface Tension: 75.4020004272461 dyne/cm; (15)Density: 1.826 g/cm3; (16)Flash Point: 255.372 °C; (17)Enthalpy of Vaporization: 76.687 kJ/mol; (18)Boiling Point: 498.646 °C at 760 mmHg
You can still convert the following datas into molecular structure:
(1)InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10);
(2)InChIKey=GLVAUDGFNGKCSF-UHFFFAOYSA-N;
(3)Smilesc12c(nc[nH]c1=S)nc[nH]2
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
hamster | LD50 | intraperitoneal | 364mg/kg (364mg/kg) | Archives of Toxicology. Vol. 32, Pg. 1, 1974. | |
man | TDLo | oral | 40mg/kg/1W-I (40mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Archives of Dermatology. Vol. 122, Pg. 1413, 1986. |
mouse | LD50 | intraperitoneal | 80mg/kg (80mg/kg) | Cancer Research. Vol. 42, Pg. 122, 1982. | |
mouse | LD50 | intravenous | 80mg/kg (80mg/kg) | Cancer Research. Vol. 42, Pg. 122, 1982. | |
mouse | LD50 | oral | 260mg/kg (260mg/kg) | Cesko-Slovenska Farmacie. Vol. 14, Pg. 389, 1965. | |
mouse | LD50 | subcutaneous | 100mg/kg (100mg/kg) | IMMUNOLOGICAL INCLUDING ALLERGIC: DECREASE IN HUMORAL IMMUNE RESPONSE | Journal of Medicinal Chemistry. Vol. 18, Pg. 320, 1975. |
rat | LD50 | intraperitoneal | 159mg/kg (159mg/kg) | Acta Poloniae Pharmaceutica. For English translation, see APPFAR. Vol. 41, Pg. 571, 1984. | |
rat | LD50 | intravenous | 250mg/kg (250mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 1467, 1970. | |
rat | LD50 | oral | 277mg/kg (277mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 15, Pg. 1037, 1973. | |
rat | LD50 | parenteral | 250mg/kg (250mg/kg) | Recent Results in Cancer Research. Vol. 52, Pg. 76, 1975. | |
rat | LD50 | subcutaneous | 90mg/kg (90mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 15, Pg. 1037, 1973. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View